LLY: Leerink Raises Target
Leerink Partners raises Eli Lilly's price target to $1232 and maintains Outperform rating
Leerink Partners analyst David Risinger maintains Eli Lilly (NYSE: LLY ) with a Outperform and raises the price target from $1119 to $1232.